http://www.urmc.rochester.edu/news/ Latest research press releases from the University of Rochester Medical Center en-us Copyright 2013, University of Rochester Medical Center http://www.urmc.rochester.edu/news/rss/ Thu, 23 May 2013 05:17:09 EST http://www.urmc.rochester.edu/images/urmc_logo_white.gif http://www.urmc.rochester.edu/news/ http://www.urmc.rochester.edu/news/story/index.cfm?id=3839 Women who live in poverty experience high rates of depression, but typical treatment plans don’t work well for many of them. Not only does this have a negative impact on their lives, it can also affect their children – who may experience related health and behavioral problems. In response, a research team at the University of Rochester Medical Center is examining alternative approaches that could change the way disadvantaged women with depression are cared for nationwide. Wed, 22 May 2013 00:00:00 EST http://www.urmc.rochester.edu/news/story/index.cfm?id=3835 Esophageal adenocarcinoma is now the fastest growing form of cancer in the United States, but gastroenterologists at URMC's Center for Advanced Therapeutic Endoscopy have been using an innovative technology to detect precancerous cells in time to prevent disease progression. Mon, 20 May 2013 00:00:00 EST http://www.urmc.rochester.edu/news/story/index.cfm?id=3830 Eli Eliav, D.M.D., M.Sc., Ph.D., has been named director of the Eastman Institute for Oral Health at the University of Rochester Medical Center and vice dean for Oral Health within the School of Medicine and Dentistry. Wed, 15 May 2013 00:00:00 EST http://www.urmc.rochester.edu/news/story/index.cfm?id=3826 Lymphangioleiomyomatosis or LAM, for short, is a rare but frequently fatal lung condition that affects almost exclusively women, usually in the prime of their lives, as they begin their careers and start families. Clinicians and scientists at URMC are working to improve the lives of LAM patients with the establishment of an official LAM Clinic and through research on the origins of the disorder. Tue, 14 May 2013 00:00:00 EST http://www.urmc.rochester.edu/news/story/index.cfm?id=3824 The University of Rochester was named a Center for AIDS Research (CFAR) by the National Institutes of Health, a designation that infuses $7.5 million into HIV/AIDS work across the University and places it amongst the best in the nation for research to improve the prevention, detection and treatment of the disease. Thu, 09 May 2013 00:00:00 EST http://www.urmc.rochester.edu/news/story/index.cfm?id=3825 We’ve all known middle-aged people who seem older because of health problems and 75-year-olds who seem younger because they’re very healthy. Scientists want to know if measuring a cancer patient’s physiological age rather than chronological age improves communication about chemotherapy and other age-related treatment issues. Thu, 09 May 2013 00:00:00 EST http://www.urmc.rochester.edu/news/story/index.cfm?id=3823 A new study appearing this week in the Journal of Health Politics, Policy, and Law catalogues community-based efforts to develop strategies and policies that – by targeting high risk housing – may hold the key to reducing lead hazards in children’s homes. Mon, 06 May 2013 00:00:00 EST http://www.urmc.rochester.edu/news/story/index.cfm?id=3818 University of Rochester Medical Center researcher Laura M. Calvi, M.D., a rising biomedical scientist, was inducted into the American Society for Clinical Investigation, one of the nation's oldest and most respected medical honor societies. Thu, 02 May 2013 00:00:00 EST http://www.urmc.rochester.edu/news/story/index.cfm?id=3819 Stephen Dewhurst, Ph.D., has been named vice dean for research at the University of Rochester School of Medicine and Dentistry. A faculty member since 1990 and past senior associate dean for basic research, Dewhurst will lead the School’s research strategic planning process and help advance its research priorities by identifying areas of excellence in which to make strategic investments; strengthening the research infrastructure; improving education and training; and promoting collaborations and alliances that will result in increased research funding. Thu, 02 May 2013 00:00:00 EST http://www.urmc.rochester.edu/news/story/index.cfm?id=3802 Tamoxifen is a time-honored breast cancer drug used to treat millions of women with early-stage and less-aggressive disease, and now a University of Rochester Medical Center team has shown how to exploit tamoxifen’s secondary activities so that it might work on more aggressive breast cancer. Tue, 23 Apr 2013 00:00:00 EST